ABSTRACT
The purpose of testing new potential medicinal products for reproductive toxicity is to identify possible hazards to human reproduction. First-pass studies are conducted in animals of reproductive age and their offspring and, if effects are seen, more refined follow-up studies are designed on a case-by-case basis to characterize further those effects and to provide an indication of the degree of potential risk to humans.
